| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 108321-89-7 | L-Valinamide,D-phenylalanyl-N-(4-nitrophenyl)- (9CI); D-PHE-VAL P-NITROANILIDE |  | C20H24N4O4 | 詳情 | 供應商 | |
| 126389-70-6 | Propanimidamide,2-[2-[(2,4-dimethoxyphenyl)methylene]hydrazinylidene]-N'-(4-ethoxyphenyl)-N-hydroxy-; Propanimidamide,2-[[(2,4-dimethoxyphenyl)methylene]hydrazono]-N-(4-ethoxyphenyl)-N'-hydroxy-(9CI) |  | C20H24N4O4 | 詳情 | 供應商 | |
| 155270-99-8 | 1H-Purine-2,6-dione,8-[(1E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-; 1H-Purine-2,6-dione,8-[2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-; Istradefylline; KW 6002 |  | C20H24N4O4 | 詳情 | 供應商 | |
| 155271-03-7 | 1H-Purine-2,6-dione,8-[2-(2,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI) |  | C20H24N4O4 | 詳情 | 供應商 | |
| 155271-10-6 | 1H-Purine-2,6-dione,8-[2-(2,4-dimethoxy-3-methylphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-, (E)-(9CI) |  | C20H24N4O4 | 詳情 | 供應商 | |
| 155271-01-5 | 1H-Purine-2,6-dione,8-[2-(2,3-dimethoxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI) |  | C20H24N4O4 | 詳情 | 供應商 | |
| 155271-61-7 | 1H-Purine-2,6-dione,8-[2-(3,5-dimethoxyphenyl)ethenyl]-1,3-diethyl-3,7-dihydro-7-methyl-, (E)-(9CI) |  | C20H24N4O4 | 詳情 | 供應商 | |
| 151539-46-7 | 1H-Purine-2,6-dione,8-[2-(3,4-dihydroxyphenyl)ethenyl]-3,7-dihydro-7-methyl-1,3-dipropyl-, (E)-(9CI); (8E)-8-[(2Z)-2-(3-hydroxy-4-oxo-1-cyclohexa-2,5-dienylidene)ethylidene ]-7-methyl-1,3-dipropyl-9H-purine-2,6-dione |  | C20H24N4O4 | 詳情 | 供應商 | |
| 6276-41-1 | 1,4-Piperazinedicarboxamide,N1,N4-bis(4-methoxyphenyl)-; 1,4-Piperazinedicarbox-p-anisidide(8CI); NSC 36317 |  | C20H24N4O4 | 詳情 | 供應商 |